AB Science, Paris (ABSCF, $0.8) was a top loser over the last three months, falling -7 to $0.8 per share. A.I.dvisor analyzed 226 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending December 24, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend. A.I.dvisor found 51 similar cases when ABSCF's price dropped within three months. In out of those 51 cases, ABSCF's price went up during the following month. Based on these historical data, A.I. thinks the odds of a Downtrend reversal for ABSCF are